Vertex Pharmaceuticals stock falls after pain drug fails in Phase 2 study
Director Russell William Teubner of Simmons First National Corp (NASDAQ:SFNC) acquired 4,050 shares of the company’s common stock on July 23, 2025, at a price of $18.50 per share, totaling $74,925. The regional bank, currently valued at $2.8 billion, offers a notable dividend yield of 4.32% and has maintained dividend payments for 52 consecutive years, according to InvestingPro data.
Following the transaction, Teubner directly owns 25,576 shares of Simmons First National Corp. He also indirectly owns 44,020 shares through a SEP-IRA and 10,660 shares through an IRA. Five analysts have recently revised their earnings estimates upward for the upcoming period, with price targets ranging from $21 to $24. For more detailed analysis and additional insights, check out the comprehensive Pro Research Report available on InvestingPro.
The purchase was made through a directed share program related to the underwritten public offering of (NASDAQ:SFNC) common stock.
In other recent news, Simmons First National Corporation reported its financial results for the second quarter of 2025, surpassing earnings per share (EPS) expectations with a figure of $0.44, compared to the anticipated $0.39. However, the company experienced a slight revenue miss, reporting $214.2 million against the forecasted $217.01 million. In a separate development, Simmons First National has priced a public offering of 16.22 million shares of its Class A common stock at $18.50 per share, raising approximately $300.07 million. The company also granted underwriters a 30-day option to purchase an additional 2.43 million shares at the same price.
Moody’s Ratings has confirmed Simmons First National’s Baa2 long-term local currency issuer rating and changed the outlook to stable from under review. Additionally, DA Davidson raised its price target on Simmons First National to $21.00 from $19.00, maintaining a Neutral rating, citing better-than-expected second-quarter results. The offering will be managed by joint book-running managers Stephens Inc., Keefe, Bruyette & Woods, and Morgan Stanley (NYSE:MS). These developments come amidst mixed market reactions to the company’s recent announcements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.